Abstract:Background Lupus is a complex chronic systemic autoimmune disease. Dysregulation of interferon-alpha (IFN-) response has been associated with the pathogenesis of lupus. Genetic variants constitute the risk factors for the development of lupus, with many SNPs identified to pose the risk of lupus. However, the functions of the host genes of these SNPs are not fully understood. Recent studies show SNP rs4850410 is associated with serum IFN- levels in European-Americans and Afican-Americans. Rs4850410 is located in the intronic region of ANKRD44 which encodes a subunit of ankyin repeat domain of protein phosphatase 6 (PP6) that is involved in an array of important cellular processes, such as the regulation of metabolism, transcription, and apoptosis. However, if ANKRD44 regulates IFN responses is unknown. In this study, we aimed to investigate the function of ANKRD44 in controlling IFN response, and its association with the pathogenesis of lupus. Methods PBMCs were collected from 46 SLE patients and 48 healthy controls. The mRNA expression of ANKRD44 and IFN-inducible genes was detected by real time PCR. The mRNA expression of ANKRD44 was measured at different time points in Raw264.7 cells during IFN stimulation. ANKRD44 was knocked down by using siRNA. The activation of IFN signaling pathway were examined by western blotting at different time points in Raw264.7 cells. Results The mRNA expression levels of ANKRD44 were decreased in PBMCs from SLE patients compared to healthy controls. The expression of ANKRD44 was downregulated when stimulating by poly(I:C) or IFN in Raw264.7 cells. Knockdown of ANKRD44 up-regulated the expression of IFN-inducible genes (such as IFIT3 and CCL2). Consistently, knockdown of ANKRD44 promoted the phosphorylation of STAT1, STAT2, JAK1 and TYK2 stimulated by IFN in Raw264.7 cells. Conclusions Our study indicates that ANKRD44 functions as a negative regulator in type I IFN signaling pathway. Decreased expression of ANKRD44 constitutes one of the mechanisms for dysregulated IFN response in SLE, which may play important roles in the pathogenesis of Lupus. Funding Source(s): This work was supported by the National Basic Research Program of China (973 program) grant 2014CB541902 and the National Natural Science Foundation of China (No.81401331).

Ring Finger Protein 215 Negatively Regulates Type I IFN Production via Blocking NF-KB p65 Activation

Ring Finger Protein 215 Negatively Regulates Type I IFN Production via Blocking NF-κB p65 Activation.

NBR1 Mediates Autophagic Degradation of IRF3 to Negatively Regulate Type I Interferon Production.

Noncanonical NF-κB Pathway Controls the Production of Type I Interferons in Antiviral Innate Immunity

Bcl6 Sets a Threshold for Antiviral Signaling by Restraining IRF7 Transcriptional Program

Downregulated NDR1 Protein Kinase Inhibits Innate Immune Response by Initiating an Mir146a-Stat1 Feedback Loop

RNF26 temporally regulates virus-triggered type I interferon induction by two distinct mechanisms.

NLRC5 Negatively Regulates the NF-κB and Type I Interferon Signaling Pathways

NLRC5 negatively regulates the NF-kappaB and type I interferon signaling pathways

RNF144B negatively regulates antiviral immunity by targeting MDA5 for autophagic degradation

The human disease-associated gene ZNFX1 controls inflammation through inhibition of the NLRP3 inflammasome

RNF90 negatively regulates cellular antiviral responses by targeting MITA for degradation

E3 ubiquitin ligase RNF6 promotes antiviral immune responses through enhancing the expression of interferon stimulated genes in myeloid cells

Nc886, a Novel Suppressor of the Type I Interferon Response Upon Pathogen Intrusion

Type I interferon/STAT1 signaling regulates UBE2M-mediated antiviral innate immunity in a negative feedback manner

P200 Family Protein IFI204 Negatively Regulates Type I Interferon Responses by Targeting IRF7 in Nucleus

Negative Regulation of RNF90 on RNA Virus-Triggered Antiviral Immune Responses Targeting MAVS

RNF39 facilitates antiviral immune responses by promoting K63-linked ubiquitination of STING

SRP54 Negatively Regulates IFN-Beta Production and Antiviral Response by Targeting RIG-I and MDA5

82 Decreased expression of ANKRD44 associates with the overactivation of type I IFN signaling pathway in SLE

MicroRNA-21: A Positive Regulator for Optimal Production of Type I and Type III Interferon by Plasmacytoid Dendritic Cells.